Treatment Response Patterns in Young Adults with Mild to Moderate Acne: A Time-Course Analysis
Keywords:
Acne vulgaris; Treatment response; Temporal patterns; Clindamycin; Benzoyl peroxide; Combination therapy; Young adults; Time-course analysis; Treatment compliance; Early responders.Abstract
Background: Understanding temporal response patterns in acne treatment is crucial for optimizing therapeutic outcomes. This study analyzed the time-course of treatment response in young adults with mild to moderate acne vulgaris. Methods: A randomized, patient-blinded study was conducted on 130 patients (aged 18-40 years) with mild to moderate acne vulgaris. Patients were randomized to receive either clindamycin 1% gel (Group 1, n=65) or combination therapy with clindamycin 1% gel and benzoyl peroxide 2.5% cream (Group 2, n=65) for 8 weeks. Treatment response was evaluated through lesion counts and Investigator Global Assessment at baseline, week 4, and week 8. Results: Combination therapy demonstrated superior efficacy with 55.0% reduction in total lesion count at week 8 compared to 41.8% with monotherapy (p=0.008). Group 2 showed a higher proportion of early responders (47.7% vs 33.8%, p=0.024) and lower non-responder rate (15.4% vs 23.1%, p=0.036). Inflammatory lesions showed more rapid improvement than non-inflammatory lesions in both groups, with Group 2 achieving 58.7% reduction versus 46.8% in Group 1 at week 8 (p=0.006). Excellent compliance rates were comparable between groups (58.5% vs 53.8%, p=0.624). Conclusion: Combination therapy demonstrates superior efficacy and more rapid onset of action compared to monotherapy, particularly for inflammatory lesions. Early response patterns may predict long-term treatment outcomes, suggesting the potential value of early therapeutic assessment in clinical practice.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright of their work and grant the journal the right of first publication.
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly cited.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.





